Q-omics provides the consensus-scored MARK2P14 profile across patient tissues and cancer cell-line models. MARK2P14 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, MARK2P14 RNA expression shows 5,006 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight STAD, and COAD as cancer lineages where MARK2P14 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.